MCF Advisors’s ResMed RMD Stock Holding History

MCF Advisors’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$364K	Sell	1,866 -1,237	-40%	-$256K	0.01%	336
2026 Q1	$697K	Buy	+3,103	New	+$773K	0.03%	203
2025 Q4	–	Sell	-12	Closed	-$3.29K	–	1177
2025 Q3	$3.29K	Buy	+12	New	+$3.28K	﹤0.01%	846
2025 Q1	–	Sell	-8	Closed	-$1.83K	–	1003
2024 Q4	$1.83K	Sell	8 -2	-20%	-$482	﹤0.01%	856
2024 Q3	$2.44K	Hold	10	–	–	﹤0.01%	828
2024 Q2	$1.92K	Hold	10	–	–	﹤0.01%	852
2024 Q1	$1.98K	Buy	10 +2	+25%	+$366	﹤0.01%	822
2023 Q4	$1.38K	Buy	8 +4	+100%	+$615	﹤0.01%	809
2023 Q3	$592	Hold	4	–	–	﹤0.01%	868
2023 Q2	$874	Hold	4	–	–	﹤0.01%	794
2023 Q1	$876	Hold	4	–	–	﹤0.01%	780
2022 Q4	$833	Hold	4	–	–	﹤0.01%	757
2022 Q3	$1K	Hold	4	–	–	﹤0.01%	770
2022 Q2	$1K	Hold	4	–	–	﹤0.01%	729
2022 Q1	$1K	Buy	+4	New	+$968	﹤0.01%	737
2021 Q4	–	Sell	-4	Closed	-$1K	–	537
2021 Q3	$1K	Buy	+4	New	+$1.09K	﹤0.01%	721

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

MCF Advisors's RMD Position: Q2 2026 in Review

MCF Advisors reduced its ResMed (RMD) stake by 40% in Q2 2026, selling an estimated $256K and leaving 1,866 shares worth $364K. The position accounts for 0.01% of the portfolio, ranked #336.

MCF Advisors first reported a position in RMD in Q3 2021 and has held it in 16 quarters since. The position peaked at $697K in Q1 2026. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

MCF Advisors held 1,866 shares of ResMed worth $364K as of Q2 2026.
MCF Advisors sold 1,237 ResMed shares in Q2 2026, an estimated $256K.
ResMed made up 0.01% of MCF Advisors's portfolio in Q2 2026, its #336 holding.
MCF Advisors first reported a position in ResMed in Q3 2021 and has held it in 16 quarters since.
MCF Advisors's ResMed position peaked at $697K in Q1 2026.
887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on MCF Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.